{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-207814","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2024-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.011270+00:00","generated_at":"2026-05-31T07:24:51.484531+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Verrica CCO Joe Bonaccorso resigns effective Aug 30, 2024; consulting role through Aug 2025","bullets":["Joe Bonaccorso resigns as Chief Commercial Officer effective August 30, 2024.","Separation benefits include 12 months base salary and up to 12 months COBRA coverage.","Consulting Agreement runs through August 30, 2025, with no cash compensation; outstanding equity continues vesting.","Company expects to enter into Release and Consulting Agreements with Bonaccorso."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-207814","json":"https://secwatch.observer/filing/0001193125-24-207814.json","markdown":"https://secwatch.observer/filing/0001193125-24-207814.md","text":"https://secwatch.observer/filing/0001193125-24-207814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/0001193125-24-207814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/d890208d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:24:51.484531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4633fbb434","claim":"Joe Bonaccorso resigned as Chief Commercial Officer at Verrica Pharmaceuticals Inc..","evidence_excerpt":"On August 21, 2024, Mr. Bonaccorso notified Verrica Pharmaceuticals Inc. (the “Company”) that he will resign from his position as Chief Commercial Officer of the Company, effective August 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312524207814/0001193125-24-207814-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}